SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-017750
Filing Date
2021-10-01
Accepted
2021-10-01 16:34:14
Documents
2
Period of Report
2021-09-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1758
2 atkisson.htm EX-24 5165
  Complete submission text file 0001567619-21-017750.txt   8343
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306
Business Address
Atkisson Erik (Reporting) CIK: 0001885915 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 211299391